1402554-75-9 Usage
Azetidine ring
Four-membered azetidine ring The compound contains a four-membered azetidine ring, which is a nitrogen-containing heterocycle.
Benzyl group
Attached to a 2-methylphenyl moiety The compound has a benzyl group (a phenyl group attached to a methyl group) connected to a 2-methylphenyl moiety.
Chiral center
Potential presence of a chiral center The compound may contain a chiral center, which is an important feature in drug design and synthesis as it can lead to different stereoisomers with varying biological activities.
Carbonyl group
Present in the structure The compound contains a carbonyl group (C=O), which is a key functional group in many pharmaceuticals and is involved in various biological interactions.
Synthetic organic compound
Derived from organic synthesis The compound is a synthetic organic compound, meaning it is created through chemical reactions involving organic molecules.
Potential pharmaceutical applications
Possible use in drug design and synthesis Due to the presence of a chiral center and a carbonyl group, this compound may have potential applications in pharmaceuticals, although further research and study are needed to fully understand its properties and uses.
Check Digit Verification of cas no
The CAS Registry Mumber 1402554-75-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,0,2,5,5 and 4 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1402554-75:
(9*1)+(8*4)+(7*0)+(6*2)+(5*5)+(4*5)+(3*4)+(2*7)+(1*5)=129
129 % 10 = 9
So 1402554-75-9 is a valid CAS Registry Number.
1402554-75-9Relevant articles and documents
SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS
-
, (2013/06/05)
Substituted cyclopropyl compounds of the formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR-119. Pharmaceutical compositions and methods of treatment are also included
